Zoom secures $1B return on 2023 Anthropic investment ahead of new funding round

Zoom’s early $51 million investment in Anthropic has grown to nearly $1.3 billion, delivering more than $1 billion of value from its AI venture stake. Zoom also beat first-quarter expectations with revenue of $1.24 billion and adjusted EPS of $1.55, raised full-year guidance to $5.96-$6.00 per share and $5.08-$5.09 billion in revenue, and authorized a new $1 billion buyback. Separately, Morgan Stanley, Rosenblatt, and Benchmark all lifted Zoom price targets on Friday.

Analysis

The market is starting to re-rate Zoom less as a post-pandemic video utility and more as a balance-sheet-light AI option with a monetizable venture stake layered on top. That matters because the Anthropic mark is now large enough to affect perception of capital allocation quality: it validates Zoom Ventures as a source of hidden NAV, but it also creates a temptation to treat a non-core asset as recurring earnings power. The right implication is not that Zoom deserves software-multiple expansion on the stake alone, but that downside is better protected than the headline operating growth rate suggests.

Second-order, the Anthropic repricing is a read-through on private AI funding appetite and compute scarcity. If a late-stage model developer can absorb capital at that scale, hyperscalers, GPU suppliers, and cloud infra names likely remain the true economic beneficiaries, while application-layer software gets forced into a more expensive AI-contention regime. For Zoom specifically, the concern is strategic: every enterprise vendor now has to justify AI features against rising third-party model costs, so the winners will be platforms that can bundle or own model access rather than simply resell it.

The main risk is that investors over-extend this into a permanent uplift for ZM multiple just as buybacks and guided beats create a near-term squeeze. The stock can keep working over weeks if estimate revisions continue, but over months the key question is whether core revenue growth re-accelerates beyond mid-single digits or the valuation simply tracks a one-time mark-to-market. A sharp private-market reset, a slower Anthropic fundraise, or any compression in enterprise software multiples would unwind the “AI asset + capital return” narrative quickly.

Consensus may be underpricing the signal from the new buyback rather than the Anthropic gain itself. Management is effectively telling you it cannot deploy excess capital into the core business at a higher return than repurchasing stock, which is more bullish for near-term EPS than for long-term enterprise value creation. That creates a cleaner trade than chasing the asset mark: own the earnings revision cycle, but fade any move that implies Zoom has become an AI platform winner rather than a beneficiary of financial engineering and option value.

Key Decisions for Investors

• Long ZM on a 1-4 week horizon into post-earnings analyst revision flow; target a move toward the upper end of new price targets, with risk defined by any breakdown back below the post-gap support and a failed follow-through in volume.
• Buy ZM Jan-2026 call spreads to capture the buyback/estimate-upgrade impulse while capping premium burn; best risk/reward if implied volatility remains elevated after the earnings move.
• Pair trade: long ZM / short a basket of slower-growth enterprise software names with weaker capital return profiles over 1-3 months; the relative trade benefits if investors reward repurchases and hidden NAV more than pure operating growth.
• Avoid extrapolating the Anthropic mark into long-duration bullishness on ZM; trim strength if the stock begins trading above a level that implies the market is capitalizing the stake at full value without assigning a discount for illiquidity and concentration risk.
• For opportunistic AI exposure, prefer semis/cloud infra over private-market beneficiaries; the durable economic rent from rising model spend is more likely to accrue to compute suppliers than to minority venture holders.